AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016
May 12, 2016
30583_dirs_2016-05-12_3eb95858-a365-43ef-a21d-4d86420b65aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-05-06
Reporting Person: Ajer Jeffrey Robert (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-06 | Common Stock | F | 679 | $80.80 | Disposed | 62393 | Direct |
Footnotes
F1: This transaction, originally due to be reported on Tuesday, May 10, 2016, is being reported late due to an administrative oversight.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19